CEGEDIM SA (CGM.PA) Stock Fundamental Analysis

EPA:CGM • FR0000053506

10.4 EUR
-0.2 (-1.89%)
Last: Sep 3, 2025, 07:00 PM
Fundamental Rating

3

Overall CGM gets a fundamental rating of 3 out of 10. We evaluated CGM against 11 industry peers in the Health Care Technology industry. CGM may be in some trouble as it scores bad on both profitability and health. CGM has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year CGM has reported negative net income.
  • CGM had a positive operating cash flow in the past year.
  • In multiple years CGM reported negative net income over the last 5 years.
  • Each year in the past 5 years CGM had a positive operating cash flow.
CGM.PA Yearly Net Income VS EBIT VS OCF VS FCFCGM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • The Return On Assets of CGM (-1.49%) is comparable to the rest of the industry.
  • CGM has a Return On Equity (-5.56%) which is in line with its industry peers.
  • CGM has a Return On Invested Capital (4.46%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CGM is significantly below the industry average of 8.41%.
  • The 3 year average ROIC (2.87%) for CGM is below the current ROIC(4.46%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.49%
ROE -5.56%
ROIC 4.46%
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
CGM.PA Yearly ROA, ROE, ROICCGM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • The Operating Margin of CGM (5.75%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CGM has declined.
  • CGM has a Gross Margin of 20.07%. This is amonst the worse of the industry: CGM underperforms 81.82% of its industry peers.
  • In the last couple of years the Gross Margin of CGM has declined.
Industry RankSector Rank
OM 5.75%
PM (TTM) N/A
GM 20.07%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
CGM.PA Yearly Profit, Operating, Gross MarginsCGM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1

2. Health

2.1 Basic Checks

  • CGM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CGM has been increased compared to 1 year ago.
  • CGM has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CGM is higher compared to a year ago.
CGM.PA Yearly Shares OutstandingCGM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CGM.PA Yearly Total Debt VS Total AssetsCGM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 1.27, we must say that CGM is in the distress zone and has some risk of bankruptcy.
  • CGM has a Altman-Z score of 1.27. This is comparable to the rest of the industry: CGM outperforms 45.45% of its industry peers.
  • CGM has a debt to FCF ratio of 27.31. This is a negative value and a sign of low solvency as CGM would need 27.31 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 27.31, CGM is in line with its industry, outperforming 54.55% of the companies in the same industry.
  • CGM has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.14, CGM is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.31
Altman-Z 1.27
ROIC/WACC1.08
WACC4.14%
CGM.PA Yearly LT Debt VS Equity VS FCFCGM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • CGM has a Current Ratio of 0.99. This is a bad value and indicates that CGM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CGM's Current ratio of 0.99 is on the low side compared to the rest of the industry. CGM is outperformed by 63.64% of its industry peers.
  • CGM has a Quick Ratio of 0.99. This is a bad value and indicates that CGM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.97, CGM is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.97
CGM.PA Yearly Current Assets VS Current LiabilitesCGM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • CGM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -97.97%.
  • The Revenue has been growing slightly by 6.25% in the past year.
  • The Revenue has been growing slightly by 5.38% on average over the past years.
EPS 1Y (TTM)-97.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1194.13%
Revenue 1Y (TTM)6.25%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%6.51%

3.2 Future

  • Based on estimates for the next years, CGM will show a very strong growth in Earnings Per Share. The EPS will grow by 21.86% on average per year.
  • The Revenue is expected to grow by 3.41% on average over the next years.
EPS Next Y-1.77%
EPS Next 2Y20.1%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CGM.PA Yearly Revenue VS EstimatesCGM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CGM.PA Yearly EPS VS EstimatesCGM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CGM. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 9.28, which indicates a very decent valuation of CGM.
  • 90.91% of the companies in the same industry are more expensive than CGM, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.69, CGM is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.28
CGM.PA Price Earnings VS Forward Price EarningsCGM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than CGM, based on the Enterprise Value to EBITDA ratio.
  • CGM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CGM is cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.29
EV/EBITDA 3.23
CGM.PA Per share dataCGM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CGM's earnings are expected to grow with 21.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.1%
EPS Next 3Y21.86%

0

5. Dividend

5.1 Amount

  • CGM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CEGEDIM SA

EPA:CGM (9/3/2025, 7:00:00 PM)

10.4

-0.2 (-1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A
Earnings (Next)09-25
Inst Owners17.29%
Inst Owner ChangeN/A
Ins Owners57.12%
Ins Owner ChangeN/A
Market Cap146.64M
Revenue(TTM)654.50M
Net Income(TTM)-14.71M
Analysts48.89
Price Target12.92 (24.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.56%
PT rev (3m)-7.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-24.49%
EPS NY rev (3m)-24.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.28
P/S 0.22
P/FCF 12.29
P/OCF 1.44
P/B 0.55
P/tB N/A
EV/EBITDA 3.23
EPS(TTM)-1.07
EYN/A
EPS(NY)1.12
Fwd EY10.78%
FCF(TTM)0.85
FCFY8.14%
OCF(TTM)7.22
OCFY69.45%
SpS46.42
BVpS18.75
TBVpS-11.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.49%
ROE -5.56%
ROCE 6.06%
ROIC 4.46%
ROICexc 4.84%
ROICexgc 19.22%
OM 5.75%
PM (TTM) N/A
GM 20.07%
FCFM 1.82%
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
ROICexc(3y)3.13%
ROICexc(5y)4.15%
ROICexgc(3y)11.62%
ROICexgc(5y)15.26%
ROCE(3y)3.91%
ROCE(5y)5.29%
ROICexgc growth 3Y0.21%
ROICexgc growth 5Y-3.19%
ROICexc growth 3Y-3.24%
ROICexc growth 5Y-2.52%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
F-Score3
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.31
Debt/EBITDA 2.3
Cap/Depr 96.22%
Cap/Sales 13.74%
Interest Coverage 4.24
Cash Conversion 77.7%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.97
Altman-Z 1.27
F-Score3
WACC4.14%
ROIC/WACC1.08
Cap/Depr(3y)92.57%
Cap/Depr(5y)94.88%
Cap/Sales(3y)13.24%
Cap/Sales(5y)13.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1194.13%
EPS Next Y-1.77%
EPS Next 2Y20.1%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue 1Y (TTM)6.25%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%6.51%
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A
EBIT growth 1Y79.81%
EBIT growth 3Y0.5%
EBIT growth 5Y1.66%
EBIT Next Year278.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.81%
FCF growth 3Y-27.43%
FCF growth 5YN/A
OCF growth 1Y4.01%
OCF growth 3Y2%
OCF growth 5Y28.33%

CEGEDIM SA / CGM.PA FAQ

What is the fundamental rating for CGM stock?

ChartMill assigns a fundamental rating of 3 / 10 to CGM.PA.


What is the valuation status of CEGEDIM SA (CGM.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to CEGEDIM SA (CGM.PA). This can be considered as Fairly Valued.


What is the profitability of CGM stock?

CEGEDIM SA (CGM.PA) has a profitability rating of 3 / 10.


Can you provide the dividend sustainability for CGM stock?

The dividend rating of CEGEDIM SA (CGM.PA) is 0 / 10 and the dividend payout ratio is 0%.